Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Measuring brain activity related to anxiety through the ear canal

Official title: Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal

Run by University of Manitoba · NCT03954483 · Data updated 2026-11-12

This study is testing if a new way to measure brain activity through the ear can help understand anxiety levels in young adults who haven't had therapy recently.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment42 (estimated)
SponsorUniversity of Manitoba
Academic / other
Locations1 site (Winnipeg, Manitoba)
StatusRecruiting
StartedOctober 16, 2023
Main results expectedOctober 1, 2026
Study endsOctober 1, 2027
Registry record updatedFebruary 18, 2026
Trial IDNCT03954483 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy males and females aged 18 to 40 with no recent psychological treatment.

Probably not a fit

Patients with a history of neurological illness, substance use disorders, or those currently on psychiatric medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the potential of using electrovestibulography (EVestG) to measure hippocampal theta rhythm, which may serve as a biomarker for anxiety disorders. It involves 42 participants aged 18 to 40 who have not received psychological treatment in the past year. Participants will be randomly assigned to receive either triazolam, buspirone, or a placebo before undergoing two experimental tasks while their brain activity is recorded from the outer ear canal. The goal is to explore the relationship between theta rhythm and anxiety levels in a non-invasive manner.

Why it matters

Potential benefit: If successful, this approach could provide a continuous, non-invasive method for diagnosing anxiety disorders.

How similar studies have gone: While the use of EVestG is relatively novel, similar approaches in measuring brain activity have shown promise in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Males and females who are between 18 and 40 years of age.

Exclusion Criteria:

* Psychological treatment in the past year or taking any psychiatric drug.
* Drugs that interact with the study drugs or that have anxiolytic/anxiogenic properties.
* Antibiotics or natural health products that inhibit/induce CYP3A4 or CYP2D6.
* History of substance use disorder or family history of substance use disorder.
* Pregnancy (or breastfeeding), left handedness, or colour blindness.
* Individuals who have a current diagnosis, or history of, a neurological illness.
* A history of stroke, head injury, loss of consciousness, epilepsy.
* Kidney or liver disease/impairment.
* COPD or sleep apnea.
* Skin lesions involving the ear canal, self-reported or as assessed in examination at the lab.
* Any unknown balance disorders, as assessed by investigator via balance test.
* Major hearing loss, self-reported or as assessed by investigator via audiogram.
* Allergic skin reactions to chemical agents including detergents.
* Heart disease, lung disease or diabetes.
* Influenza, Covid-19, or flu-like symptoms.
* Recovering from an accident, injury, or operation.

Where it's running

  • Riverview Health Centre
    Winnipeg, Manitoba, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.